Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapyfor Urothelial Cancer35 locations incl. GilbertSponsor: Bristol-Myers SquibbSex: All·Age: 18+Code: NCT07106762·Phase 2, Phase 3·RecruitingApply to this trial
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)for Chronic Graft-Versus-Host Disease (cGVHD)26 locations incl. DuarteSponsor: Deciphera Pharmaceuticals, LLCSex: All·Age: 18+Code: NCT06619561·Phase 2·RecruitingApply to this trial
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutationfor Metastatic Breast Cancer36 locations incl. ScottsdaleSponsor: LeonaBioSex: All·Age: 18+Code: NCT05696626·Phase 3·RecruitingApply to this trial
FOG-001 in Locally Advanced or Metastatic Solid Tumorsfor Cancer31 locations incl. PhoenixSponsor: Parabilis Medicines, Inc.Sex: All·Age: 18+Code: NCT05919264·Phase 1, Phase 2·RecruitingApply to this trial
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.for Melanoma31 locations incl. FayettevilleSponsor: PfizerSex: All·Age: 16+Code: NCT05355701·Phase 1·RecruitingApply to this trial
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancerfor Non-small Cell Lung Cancer40 locations incl. BirminghamSponsor: BioNTech SESex: All·Age: 18+Code: NCT06712316·Phase 2, Phase 3·RecruitingApply to this trial
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fractionfor Heart Failure88 locations incl. Alexander CitySponsor: CytokineticsSex: All·Age: 18 - 85Code: NCT06736574·Phase 3·RecruitingApply to this trial
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)for Head and Neck Squamous Cell Carcinoma29 locations incl. DuarteSponsor: Tempus AISex: All·Age: 18+Code: NCT06163534·RecruitingApply to this trial
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilastfor Idiopathic Pulmonary FibrosisDrug: Nerandomilast58 locations incl. BirminghamSponsor: Boehringer IngelheimSex: All·Age: 18+Code: NCT06238622·Phase 3·RecruitingApply to this trial
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Diseasefor Parkinson's DiseaseDrug: Prasinezumab46 locations incl. BirminghamSponsor: Hoffmann-La RocheSex: All·Age: 50 - 85Code: NCT07174310·Phase 3·RecruitingApply to this trial
A Phase 1/1b Study of IAM1363 in HER2 Cancersfor HER2 Mutation-Related Tumors29 locations incl. La JollaSponsor: Iambic Therapeutics, IncSex: All·Age: 18+Code: NCT06253871·Phase 1·RecruitingApply to this trial
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)for Tricuspid Regurgitation36 locations incl. PhoenixSponsor: P+F Products + Features USA Inc.Sex: All·Age: 18+Code: NCT06137807·RecruitingApply to this trial
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancerfor Prostate Cancer44 locations incl. HomewoodSponsor: Curium US LLCSex: Male·Age: 18+Code: NCT06235151·Phase 3·RecruitingApply to this trial
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumabfor Acute Respiratory Distress Syndrome (ARDS)Drug: Bevacizumab40 locations incl. BirminghamSponsor: PPD Development, LPSex: All·Age: 18+Code: NCT06701656·Phase 2·RecruitingApply to this trial
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluationfor Bladder Carcinoma33 locations incl. BirminghamSponsor: Guardant Health, Inc.Sex: All·Age: 18+Code: NCT05059444·RecruitingApply to this trial
Nectero EAST System Clinical Studyfor Abdominal Aortic Aneurysm37 locations incl. ScottsdaleSponsor: Nectero Medical, Inc.Sex: All·Age: 21 - 85Code: NCT06001918·Phase 2, Phase 3·RecruitingApply to this trial
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnessesfor Adjustment Disorder30 locations incl. BirminghamSponsor: Reunion Neuroscience IncSex: All·Age: 18 - 80Code: NCT07002034·Phase 2·RecruitingApply to this trial
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]for Myositis47 locations incl. GlendaleSponsor: PfizerSex: All·Age: 18+Code: NCT05895786·Phase 3·RecruitingApply to this trial
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimabfor Acute Respiratory Distress Syndrome (ARDS)40 locations incl. BirminghamSponsor: PPD Development, LPSex: All·Age: 18+Code: NCT06701682·Phase 2·RecruitingApply to this trial
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubartfor Acute Respiratory Distress Syndrome (ARDS)Drug: Cohort B: paridiprubart40 locations incl. BirminghamSponsor: PPD Development, LPSex: All·Age: 18+Code: NCT06701669·Phase 2·RecruitingApply to this trial
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)for Acute Respiratory Distress Syndrome (ARDS)40 locations incl. BirminghamSponsor: PPD Development, LPSex: All·Age: 18+Code: NCT06703073·Phase 2·RecruitingApply to this trial
SELUTION4BTK Trialfor Peripheral Arterial Disease30 locations incl. ChandlerSponsor: M.A. Med Alliance S.A.Sex: All·Age: 18+Code: NCT05055297·RecruitingApply to this trial
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinomafor Cutaneous Squamous Cell Carcinoma (CSCC)Drug: Cemiplimab47 locations incl. PhoenixSponsor: Regeneron PharmaceuticalsSex: All·Age: 18+Code: NCT06585410·Phase 3·RecruitingApply to this trial
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)for Atrial Fibrillation43 locations incl. PhoenixSponsor: Biosense Webster, Inc.Sex: All·Age: 18 - 80Code: NCT06455098·RecruitingApply to this trial
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomidefor Multiple MyelomaDrug: Talquetamab49 locations incl. ClovisSponsor: Janssen Research & Development, LLCSex: All·Age: 18+Code: NCT06208150·Phase 3·RecruitingApply to this trial
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosisfor Venous Thromboembolism48 locations incl. ScottsdaleSponsor: Inari MedicalSex: All·Age: 18+Code: NCT05701917·RecruitingApply to this trial
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2for Single Ventricle Heart Disease37 locations incl. PhoenixSponsor: Mezzion Pharma Co. LtdSex: All·Age: 12 - 18Code: NCT05918211·Phase 3·RecruitingApply to this trial
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitisfor Colitis, Ulcerative36 locations incl. PhoenixSponsor: Bristol-Myers SquibbSex: All·Age: 2 - 17Code: NCT05076175·Phase 2, Phase 3·RecruitingApply to this trial
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndromefor Dravet Syndrome32 locations incl. BirminghamSponsor: EpygenixSex: All·Age: 2+Code: NCT04462770·Phase 3·RecruitingApply to this trial
A Safety Study of SEA-CD70 in Patients With Myeloid Malignanciesfor Myelodysplastic Syndrome49 locations incl. BirminghamSponsor: Seagen, a wholly owned subsidiary of PfizerSex: All·Age: 18+Code: NCT04227847·Phase 1·RecruitingApply to this trial
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injuryfor Acute Kidney Injury38 locations incl. BirminghamSponsor: SeaStar MedicalSex: All·Age: 18+Code: NCT05758077·RecruitingApply to this trial
A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)for Lupus Erythematosus, SystemicDrug: BMS-98635340 locations incl. PhoenixSponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanySex: All·Age: 16+Code: NCT07015983·Phase 2·RecruitingApply to this trial
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)for Lower Extremity Acute Limb Ischemia32 locations incl. ScottsdaleSponsor: Penumbra Inc.Sex: All·Age: 18+Code: NCT06747117·RecruitingApply to this trial
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)for Graft-versus-host Disease (GVHD)Drug: Ruxolitinib30 locations incl. Palo AltoSponsor: Incyte CorporationSex: All·Age: 18+Code: NCT06615050·Phase 3·RecruitingApply to this trial
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)for Platinum-resistant Ovarian CancerDrug: Bevacizumab32 locations incl. MobileSponsor: Genelux CorporationSex: Female·Age: 18+Code: NCT05281471·Phase 3·RecruitingApply to this trial
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesionsfor In-Stent Restenosis28 locations incl. BirminghamSponsor: Concept Medical Inc.Sex: All·Age: 18 - 110Code: NCT05908331·RecruitingApply to this trial
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)for Relapsed Hematologic MalignancyDrug: Emavusertib27 locations incl. PhoenixSponsor: Curis, Inc.Sex: All·Age: 18+Code: NCT03328078·Phase 1, Phase 2·RecruitingApply to this trial
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEMfor Heart Failure37 locations incl. FairhopeSponsor: Cordio MedicalSex: All·Age: 22+Code: NCT06378632·RecruitingApply to this trial
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)for Systemic Lupus Erythematosus31 locations incl. AuroraSponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanySex: All·Age: 18+Code: NCT05869955·Phase 1·RecruitingApply to this trial
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumorsfor HR+ Breast Cancer18 locations incl. DuarteSponsor: NiKang Therapeutics, Inc.Sex: All·Age: 18+Code: NCT07029399·Phase 1·RecruitingApply to this trial